Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 3,100.00
+150.00 (5.08%)
At close: Sep 4, 2026
Vivozon Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,723 | 3,138 | 6,525 | 7,987 | 2,351 | 13,799 |
Short-Term Investments | 1,980 | 2,020 | 2,211 | 5,330 | 11,600 | 14,880 |
Trading Asset Securities | - | - | 1,252 | 4,404 | 12,448 | 35,376 |
Cash & Short-Term Investments | 10,703 | 5,158 | 9,988 | 17,721 | 26,400 | 64,055 |
Cash Growth | 44.19% | -48.36% | -43.64% | -32.88% | -58.79% | -29.36% |
Accounts Receivable | - | 9,739 | 11,900 | - | 8,847 | 10,712 |
Other Receivables | - | 355.87 | 368.04 | - | 347.19 | 2,428 |
Receivables | - | 10,223 | 14,409 | - | 9,694 | 13,163 |
Inventory | 16,240 | 15,849 | 19,637 | 12,994 | 11,199 | 16,034 |
Prepaid Expenses | - | 826.97 | 269.57 | - | 20.8 | 421.39 |
Other Current Assets | 8,600 | 1,482 | 103.33 | 14,423 | 248.44 | 2,659 |
Total Current Assets | 35,543 | 33,539 | 44,407 | 45,138 | 47,562 | 96,333 |
Property, Plant & Equipment | 25,250 | 26,272 | 31,814 | 25,521 | 33,968 | 32,807 |
Long-Term Investments | 84,031 | 86,284 | 94,560 | 91,484 | 95,242 | 45,857 |
Other Intangible Assets | 3,434 | 3,686 | 4,190 | 4,631 | 5,574 | 8,612 |
Long-Term Accounts Receivable | - | 0 | -0 | - | - | - |
Long-Term Deferred Tax Assets | - | - | - | - | - | 3,431 |
Long-Term Deferred Charges | 14,436 | 14,716 | 7,864 | 6,209 | 3,437 | 2,880 |
Other Long-Term Assets | 837.2 | 984.37 | 1,614 | 662.93 | 1,006 | 653.97 |
Total Assets | 163,531 | 165,481 | 184,449 | 173,647 | 187,074 | 194,471 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 7,765 | 11,827 | 10,632 | 6,152 | 6,622 |
Accrued Expenses | - | 1,564 | 1,575 | 1,532 | 1,848 | 2,167 |
Short-Term Debt | 32,196 | 40,929 | 34,476 | 39,996 | 52,572 | 67,993 |
Current Portion of Long-Term Debt | - | - | - | - | 5,604 | 867.11 |
Current Portion of Leases | 1,021 | 878.7 | 1,182 | 624.62 | 653.17 | 610.93 |
Current Income Taxes Payable | - | - | 30.1 | - | - | - |
Current Unearned Revenue | - | 1,851 | 1,906 | 3,504 | 3,685 | 3,685 |
Other Current Liabilities | 20,541 | 24,724 | 21,215 | 8,490 | 8,746 | 7,078 |
Total Current Liabilities | 53,759 | 77,712 | 72,211 | 64,779 | 79,261 | 89,023 |
Long-Term Debt | - | - | - | - | - | 13,958 |
Long-Term Leases | 253.38 | 533.97 | 841.95 | 994.18 | 1,481 | 685.36 |
Pension & Post-Retirement Benefits | 2,459 | 4,060 | 3,807 | 2,600 | 1,809 | 2,288 |
Long-Term Deferred Tax Liabilities | 972.12 | 972.12 | 923.51 | 923.51 | 927.93 | 1,823 |
Other Long-Term Liabilities | 10,785 | 9,538 | 238.67 | 283.74 | 130.07 | 150.4 |
Total Liabilities | 68,229 | 92,816 | 78,022 | 69,580 | 83,609 | 107,928 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 151,799 | 125,262 | 125,262 | 120,529 | 117,022 | 84,953 |
Additional Paid-In Capital | 256,264 | 250,604 | 249,419 | 245,296 | 243,684 | 216,611 |
Retained Earnings | -311,701 | -303,792 | -271,829 | -261,313 | -257,365 | -216,914 |
Treasury Stock | -6.56 | -10.05 | -13.12 | -18.19 | - | - |
Comprehensive Income & Other | -1,053 | 601.24 | 3,588 | -427.4 | 125.39 | 469.82 |
Total Common Equity | 95,303 | 72,665 | 106,427 | 104,067 | 103,466 | 85,120 |
Minority Interest | - | - | - | - | - | 1,422 |
Shareholders' Equity | 95,303 | 72,665 | 106,427 | 104,067 | 103,466 | 86,542 |
Total Liabilities & Equity | 163,531 | 165,481 | 184,449 | 173,647 | 187,074 | 194,471 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 33,471 | 42,341 | 36,500 | 41,615 | 60,310 | 84,115 |
Net Cash (Debt) | -22,768 | -37,183 | -26,512 | -23,894 | -33,910 | -20,060 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -431.01 | -751.00 | -555.09 | -500.74 | -779.45 | -615.13 |
Filing Date Shares Outstanding | 55.69 | 49.55 | 49.38 | 47.21 | 46.81 | 33.98 |
Total Common Shares Outstanding | 55.69 | 49.55 | 49.38 | 47.21 | 46.81 | 33.98 |
Working Capital | -18,215 | -44,173 | -27,804 | -19,640 | -31,699 | 7,310 |
Book Value Per Share | 1711.41 | 1466.51 | 2155.28 | 2204.51 | 2210.40 | 2504.91 |
Tangible Book Value | 91,869 | 68,979 | 102,237 | 99,436 | 97,892 | 76,508 |
Tangible Book Value Per Share | 1649.75 | 1392.12 | 2070.44 | 2106.41 | 2091.33 | 2251.47 |
Land | 6,037 | 6,037 | 6,037 | 6,037 | 6,037 | 6,183 |
Buildings | 6,602 | 10,694 | 6,835 | 6,678 | 6,557 | 7,886 |
Machinery | 11,335 | 23,766 | 23,153 | 23,401 | 20,015 | 22,216 |
Construction In Progress | 22.5 | 47.23 | 7,598 | 1,943 | 12,132 | 9,142 |